Position in INCY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$88,307
+$14,988 QoQ
Shares Held
779
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 134 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $2,462,425 across 22 Biotechnology names. INCY ranks #5 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAI |
Caris Life Sciences, Inc.
|
100,000 | $1,782,000 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
494 | $245,384 | |
| 3 | FTRE |
Fortrea Holdings Inc.
|
5,746 | $99,980 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
2,288 | $89,254 | |
| 5 | INCY |
Incyte Corp
This page
|
779 | $88,307 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
2,675 | $45,394 | |
| 7 | AKTS |
Aktis Oncology, Inc.
|
1,000 | $32,230 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
535 | $29,178 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,307 | 779 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $73,319 | 779 | Shares | Sole | 2026-04-29 | |
| 2025-09-30 | $66,066 | 779 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $53,049 | 779 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $47,168 | 779 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $53,805 | 779 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $51,491 | 779 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $47,222 | 779 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $44,379 | 779 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $48,913 | 779 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $45,002 | 779 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $48,492 | 779 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $56,298 | 779 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $62,569 | 779 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $51,912 | 779 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $59,180 | 779 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $3,971 | 50 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $57,178 | 779 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $53,579 | 779 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $16,489 | 196 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $4,063 | 50 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,349 | 50 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $4,487 | 50 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,198 | 50 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,661 | 50 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||